Key result
In vivo expression of a recombinant antibody (PLN-Ab) targeting phospholamban accelerated calcium transient decay and enhanced cardiac contractility in diabetic mouse hearts.
Why the study?
Does a recombinant antibody targeting phospholamban improve cardiac contractility in preclinical mouse and rat models?
Does a recombinant antibody targeting phospholamban improve cardiac contractility in preclinical mouse and rat models?
In vivo expression of a recombinant antibody targeting phospholamban improves cardiac contractility in preclinical models, offering a potential novel therapeutic approach for heart failure.
Many cardiovascular disease states end in progressive heart failure. Changes in intracellular calcium handling, including a reduced activity of the sarcoplasmic reticulum calcium pump (SERCA), contribute to this contractile dysfunction. As the regulatory protein phospholamban can inhibit the calcium pump, we evaluated it as a potential target to improve cardiac function. In this study, we describe a recombinant antibody-based protein (PLN-Ab) that binds to the cytoplasmic domain of phospholamban. Fluorescence resonance energy transfer (FRET) studies suggest that PLN-Ab mimics the effects of phospholamban phosphorylation. PLN-Ab accelerated the decay of the calcium transient when expressed in neonatal rat and adult mouse ventricular cardiac myocytes. In addition, direct injection of adenovirus encoding PLN-Ab into the diabetic mouse heart enhanced contractility when measured in vivo by echocardiography and in ex vivo Langendorff perfused hearts. The PLN-Ab provides a novel therapeutic approach to improving contractility through in vivo expression of an antibody inside cardiac myocytes.
No takes yet. Share an insight, caveat, or question.
Meyer et al. (2004) studied Heart failure / Contractile dysfunction. Recombinant antibody-based protein (PLN-Ab) was evaluated on Cardiac contractility and calcium transient decay. In vivo expression of a recombinant antibody (PLN-Ab) targeting phospholamban accelerated calcium transient decay and enhanced cardiac contractility in diabetic mouse hearts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: